Colorectal cancer: open trials in Mexico

11 open trials have a site in Mexico. Registry data; only the trial team decides who can take part.

NCT07228832
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Trial Treatment · Phase 3 · Summit Therapeutics
Aguas Calientes · Mexico City · Monterrey · Oaxaca City
Registry updated 2026-11-05
NCT06997497
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Centro de Investigación Oncológica Galerías SC (Site 0408), Aguascalientes · Centro de Inmuno Oncología de Occidente SA de CV (Site 0403), Guadalajara · Higiea Oncologia (Site 0404), Mexico City · Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" (Site 0401), Monterrey · Centro de Investigacion Clinica de Oaxaca (Site 0402), Oaxaca City · Oncare Oncology (Servicios de Oncologia Médica Integral S.A. de C.V. - unidad San Pedro) (Site 0407), San Pedro Garza García
Registry updated 2026-11-04
NCT06750094
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Centro Oncologico de Chihuahua, Chihuahua City · Actualidad Basada en la Investigación del Cáncer, Guadalajara · Centro Oncologico Personalizado Cope S De R L De C V, Mexico City · Instituto Nacional de Cancerologia, Mexico City · Hospital Universitario Dr. Jose Eleuterio González, Monterrey · Oncocenter, Puebla City · Cuidados Oncologicos, Querétaro · Health Pharma Queretaro SA de CV, Querétaro · COI Centro Oncologico Internacional Tijuana, Tijuana
Registry updated 2026-11-03
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Trial Treatment · Phase 1/2 · Pfizer
INCAN, Mexico City · Hospital MAC Periferico Sur, Mexico City · COI Centro Oncologico Internacional S.A.P.I. de C.V., Mexico City · Hospital Universitario Dr. Jose Eleuterio González, Monterrey · Hospital Reforma, Oaxaca City · Oaxaca Site Management Organization, Oaxaca City
Registry updated 2026-10-28
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Medical Care & Research Sa de Cv, Mérida · Centro de Atenciă"N E Investigaciă"N Clă Nica En Oncologă A, Mérida · Cryptex Investigacion Clinica S.A. de C.V., México
Registry updated 2026-10-26
NCT07221357
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Chihuahua City · Mexico City · Tlalpan
Registry updated 2026-10-23
NCT07811193
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Trial Treatment · Phase 2 · Vividion Therapeutics, Inc.
Grupo Medico ASSET S.C, Benito Juárez · Renati Innovation SAPI de CV, Guadalajara · Oncare Viaducto Nápoles, Mexico City · Instituto Nacional de Cancerologia, Mexico City · Hospital Zambrano Hellion, Monterrey · Hospital Universitrio Dr. José Eleuterio González. Servicio de Oncologia, Monterrey
Registry updated 2026-10-21
NCT06885034
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Cuernavaca · Mexico City · San Pedro Garza García · Tuxtla Gutiérrez
Registry updated 2026-10-19
NCT06252649
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Trial Treatment · Phase 3 · Amgen
Centro Especializado en Investigacion y Tratamiento Oncologicos SC, Benito Juárez · Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City · Health Pharma Professional Research SA de CV, Mexico City · Hospital Universitario Dr. Jose Eleuterio González, Monterrey
Registry updated 2026-09-03
NCT07225309
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Trial Treatment · Memorial Sloan Kettering Cancer Center
Instituto Nacional de Cancerología (INCan), Mexico City
Registry updated 2026-08-03
NCT05855200
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Trial Treatment · Phase 3 · GlaxoSmithKline
DF · Guadalajara · Mexico City · Oaxaca City · San Pedro Garza García · Tijuana
Registry updated 2026-01-23

All Colorectal cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error